People - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 3, Issue 2

People on the move in February 2007.

Greenwich, CT (Feb. 20)Aptuit, Inc. ( announced a series of promotions and shifting of responsibility in its senior management team. These changes include: Frank J. Wright becomes vice-chairman, responsible for external value creation and global integration activities and also has been nominated to the company's board of managers. Scott L. Houlton becomes chief operating officer, with responsibility for scientific operations, business process Improvement, human resources, clinical operations, and capital development. Michael J. Butler, president, scientific operations, will take responsibility for Aptuit's technology and innovation investment activities, including research and development. And Robert G. Burford, managing director, has assumed additional responsibility as chairman of the management committee of Aptuit Consulting.

InformexUSA, San Francisco (Feb. 14)—Halocarbon Products Corporation (River Edge, NJ, named Mary Ellen Rubinstein marketing manager with responsibility for three product lines: inhalation anesthetics; fluorochemicals; and oils, greases, and waxes. Halocarbon is a producer of specialty fluorochemicals.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here